tetano
Editor, Senior Moderator
J Glob Health
. 2023 Jan 14;13:06001.
doi: 10.7189/jogh.13.06001.
Economic evaluation of COVID-19 vaccination: A systematic review
Auliasari Meita Utami[SUP] #[/SUP][SUP] 1 [/SUP], Farida Rendrayani[SUP] #[/SUP][SUP] 1 [/SUP], Qisty Aulia Khoiry[SUP] #[/SUP][SUP] 1 [/SUP], Dita Noviyanti[SUP] 1 [/SUP], Auliya A Suwantika[SUP] 1 2 [/SUP], Maarten J Postma[SUP] 2 3 4 [/SUP], Neily Zakiyah[SUP] 1 2 [/SUP]
Affiliations
Abstract
Background: Safe and effective vaccination is considered to be the most critical strategy to fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity protection. We aimed to systematically review the economic evaluation of COVID-19 vaccination globally.
Methods: We performed a systematic search to identify relevant studies in two major databases (MEDLINE/PubMed and EBSCO) published until September 8, 2022. After deduplication, two researchers independently screened the study titles and abstracts according to pre-determined inclusion and exclusion criteria. The remaining full-text studies were assessed for eligibility. We assessed their quality of reporting using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 checklist and summarized and narratively presented the results.
Results: We identified 25 studies that assessed the economic evaluation of COVID-19 vaccination worldwide by considering several input parameters, including vaccine cost, vaccine efficacy, utility value, and the size of the targeted population. All studies suggested that COVID-19 vaccination was a cost-effective or cost-saving intervention for mitigating coronavirus transmission and its effect in many countries within certain conditions. Most studies reported vaccine efficacy values ranging from 65% to 75%.
Conclusions: Given the favorable cost-effectiveness profile of COVID-19 vaccines and disparities in affordability across countries, considering prioritization has become paramount. This review provides comprehensive insights into the economic evaluation of COVID-19 vaccination that will be useful to policymakers, particularly in highlighting preventive measures and preparedness plans for the next possible pandemic.
. 2023 Jan 14;13:06001.
doi: 10.7189/jogh.13.06001.
Economic evaluation of COVID-19 vaccination: A systematic review
Auliasari Meita Utami[SUP] #[/SUP][SUP] 1 [/SUP], Farida Rendrayani[SUP] #[/SUP][SUP] 1 [/SUP], Qisty Aulia Khoiry[SUP] #[/SUP][SUP] 1 [/SUP], Dita Noviyanti[SUP] 1 [/SUP], Auliya A Suwantika[SUP] 1 2 [/SUP], Maarten J Postma[SUP] 2 3 4 [/SUP], Neily Zakiyah[SUP] 1 2 [/SUP]
Affiliations
- PMID: 36637810
- DOI: 10.7189/jogh.13.06001
Abstract
Background: Safe and effective vaccination is considered to be the most critical strategy to fight coronavirus disease 2019 (COVID-19), leading to individual and herd immunity protection. We aimed to systematically review the economic evaluation of COVID-19 vaccination globally.
Methods: We performed a systematic search to identify relevant studies in two major databases (MEDLINE/PubMed and EBSCO) published until September 8, 2022. After deduplication, two researchers independently screened the study titles and abstracts according to pre-determined inclusion and exclusion criteria. The remaining full-text studies were assessed for eligibility. We assessed their quality of reporting using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 checklist and summarized and narratively presented the results.
Results: We identified 25 studies that assessed the economic evaluation of COVID-19 vaccination worldwide by considering several input parameters, including vaccine cost, vaccine efficacy, utility value, and the size of the targeted population. All studies suggested that COVID-19 vaccination was a cost-effective or cost-saving intervention for mitigating coronavirus transmission and its effect in many countries within certain conditions. Most studies reported vaccine efficacy values ranging from 65% to 75%.
Conclusions: Given the favorable cost-effectiveness profile of COVID-19 vaccines and disparities in affordability across countries, considering prioritization has become paramount. This review provides comprehensive insights into the economic evaluation of COVID-19 vaccination that will be useful to policymakers, particularly in highlighting preventive measures and preparedness plans for the next possible pandemic.